CSL
WHO guidance on PBM implementation: Strategies for effective dissemination and communication
WHO guidance on PBM implementation: Strategies for effective dissemination and communication
Developing VET Algorithms to Support the Standardisation of Perioperative Haemostatis Management and Improvement of Transfusion Outcomes
Patient blood management in cardiac surgery and obstetric: from coagulation monitoring with Quantra® & qLabs® FIB to comprehensive autotransfusion (Platelets + RBC) with same™
Learnings from the latest clinical trials targeting trauma-induced coagulopathy
Lorem ipsum odor amet, consectetuer adipiscing elit. Dictum ipsum per platea taciti libero sapien ullamcorper et purus. Lectus inceptos ligula nibh quisque luctus maximus. Nascetur primis diam massa ut elit
Despite studies supporting a restrictive red cell transfusion strategy in many medical situations, a more liberal strategy is still widely used in patients who need extracorporeal membrane oxygenation (ECMO), Alexander
Anticoagulation treatment has been revolutionised in the past few decades with the development of drugs that increasingly target individual components of the coagulation cascade. Yet the quest to find improved
Tranexamic acid (TXA) is safe to use to prevent bleeding in patients at the time of surgery, even in those at risk of thrombosis, according to Patrick Meybohm (University Hospital
NATA: Network for the advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and ther healthcare professionals.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.